Ocular Endpoint Protocol Review
Before your trial begins, let’s ensure ocular assessments won’t slow down your trial later.
When ocular endpoints are overlooked during protocol development, it can cause:
🚫 IRB pushback
🚫 Referral bottlenecks
🚫 Missed enrollment milestones
🚫 Amendments that cost weeks and thousands
What You’ll Get in This Review
In just 30 minutes, our clinical operations team will:
- Audit your current protocol language around ocular endpoints
- Red flags we’ve seen lead to real-world delays
- Suggest operational improvements to reduce patient burden
- Recommend integration options that fit your timeline and site structure
- Show how to reduce dropout (from 30% to as low as 9%) and meet enrollment targets faster
"While working with 20/20 Onsite for previous and current studies, we have been able to provide ophthalmological services that were previously not feasible for our clinical units. Doing so has been very successful in providing safety and ophthalmological oversight of study participants – as required by good clinical practices and the sponsor protocol."
Don’t Wait Until First Patient In
The earlier we review your protocol, the more we can help you save on time, budget, and headaches.
Book your complimentary review today
Point of Need
100%
Screening timelines met across all business operations.
Data Integrity
98%
Data accuracy submission rate.
Patient Retention
91%
Patient retention rate vs industry standard 70%.
Patient Centricity
95+
Patient NPS score.
Copyright © 2025. | Privacy Policy